Dimitri Van der Linden

Prof. Dimitri Van der Linden

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
FLFanny Lanternier
Fanny Lanternier
SMSeyed Alireza Mahdaviani
Seyed Alireza Mahdaviani
EBElisa Barbati
Elisa Barbati
HCHélène Chaussade
Hélène Chaussade
YKYatrika Koumar
Yatrika Koumar
APAnne Puel
Anne Puel

1 June 2020 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
FPfiammetta piersigilli
fiammetta piersigilli
KCKatherine Carkeek
Katherine Carkeek
CHCatheline Hocq
Catheline Hocq
BGBénédicte van Grambezen
Bénédicte van Grambezen
CHCorinne Hubinont
Corinne Hubinont
ODOlivier Danhaive
Olivier Danhaive

26 July 2016 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
FKFatima Kakkar
Fatima Kakkar
DLDimitri Van der Linden
Dimitri Van der Linden
SVSilvie Valois
Silvie Valois
FMFrancois Maurice
Francois Maurice
MOMarion Onnorouille
Marion Onnorouille
VLValerie Lamarre
Valerie Lamarre
Little is known on outcomes after transition to adult care among adolescents with perinatal HIV infection. Though there is data from other chronic pediatric diseases suggesting increased morbidity and mortality following transfer to adult care, this has not well been studied among the first wave of survivors of perinatal HIV infection. The primary objective of this study was to determine outcomes after transition to adult care among a cohort of HIV-infected adolescents in Québec, Canada. Secondary objectives were to document participant experiences with the transition process, identify barriers to successful transition, and potential changes to improve the transition process. Clinic records were reviewed to identify all perinatally-infected youth who transitioned from the Centre Maternel et Infantile sur le Sida pediatric HIV clinic (Montreal) at age 18 to an adult care provider between 1999 and 2012. Transitioned patients were contacted using last available patient or parental listed phone number on hospital record, internet based telephone directory, or social media. A standardized questionnaire was administered by telephone or in-person interview, and copies of current medical records obtained from treating physicians. Forty-five patients were transferred between 1999 and 2012, among whom 25 consented to the study, eight were lost to follow-up, eight refused participation, and four were deceased. Overall 76 % of patients remained engaged in care, defined by at least one physician visit within 6 months of the interview. Over 50 % reported difficulty with adherence to their current drug regimens. At one-year post-transfer, there was a decrease in the proportion of patients with CD4 count >500 cells/mm3 from 64 to 29 %, and a statistically significant decrease in absolute CD4 count (mean 370 vs 524 cells/mm3, p = 0.04.). The majority (92 %) of participants felt that 18 was too young an age to transfer to adult care, and provided suggestions for improving the transition process. This group of perinatally-infected youth remained engaged in care after transition, however difficulties with adherence and assuming responsibility for their own care were identified as issues in their post-transition care. The high rate of mortality among them and the changes to their health status post-transition suggest that further work is necessary to document the health outcomes of this group in larger, more diverse cohort settings.

22 September 2021 in Viruses
Verified
Journal Article
Open access
PDF file
BNBrieuc Van Nieuwenhuyse
Brieuc Van Nieuwenhuyse
CGChristine C. Galant
Christine C. Galant
BBBénédicte Brichard
Bénédicte Brichard
PDPierre-Louis Docquier
Pierre-Louis Docquier
SDSarah Djebara
Sarah Djebara
OCOlga Chatzis
Olga Chatzis
Phage therapy (PT) shows promising potential in managing biofilm infections, which include refractory orthopedic infections. We report the case of a 13-year-old girl who developed chronic polymicrobial biofilm infection of a pelvic bone allograft after Ewing’s sarcoma resection surgery. Chronic infection by Clostridium hathewayi, Proteus mirabilis and Finegoldia magna was worsened by methicillin-susceptible Staphylococcus aureus exhibiting an inducible Macrolides-Lincosamides-Streptogramin B resistance phenotype (iMLSB). After failure of conventional conservative treatment, combination of in situ anti-S. aureus PT with surgical debridement and intravenous antibiotic therapy led to marked clinical and microbiological improvement, yet failed to prevent a recurrence of infection on the midterm. This eventually led to surgical graft replacement. Multiple factors can explain this midterm failure, among which incomplete coverage of the polymicrobial infection by PT. Indeed, no phage therapy against C. hathewayi, P. mirabilis or F. magna could be administered. Phage-antibiotic interactions were investigated using OmniLog® technology. Our results suggest that phage-antibiotic interactions should not be considered “unconditionally synergistic”, and should be assessed on a case-by-case basis. Specific pharmacodynamics of phages and antibiotics might explain these differences. More than two years after final graft replacement, the patient remains cured of her sarcoma and no further infections occurred.

17 July 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RKRichard MBUSA KAMBALE
Richard MBUSA KAMBALE
GNGaylord Amani Ngaboyeka
Gaylord Amani Ngaboyeka
JNJoseph Ntagerwa Ntagazibwa
Joseph Ntagerwa Ntagazibwa
MBMarie-Hélène Igega Bisimwa
Marie-Hélène Igega Bisimwa
LKLisa Yvette Kasole
Lisa Yvette Kasole
DLDimitri Van der Linden
Dimitri Van der Linden
Severe acute malnutrition (SAM) remains a serious public health concern in low- and middle-income countries. Little is known about treatment outcomes of child inpatients in Intensive Therapeutic and Feeding Units. This study aimed to assess treatment outcomes of SAM and identify factors associated with mortality among children treated at Saint Joseph Nutritional Center, South Kivu, Eastern Democratic Republic of Congo. A retrospective hospital-based cross-sectional study was conducted on medical records of 633 severely malnourished children followed as inpatients at Saint Joseph Nutritional Center from July 2017 to December 2018. Data were entered, thoroughly cleaned and analyzed in SPSS version 25. Univariable and multivariable logistic regression model were fitted to identify factors associated with mortality. Among 633 patients admitted with SAM, 13.1% were lost to follow-up and 9.2% died while in hospital. Children with late referral to the health facility (> 14 days) after the onset of main external malnutrition signs had 2.03 times higher odds of death than those referred less than 14 days [AOR = 2.03 at 95%CI (1.12, 3.68)]. The odds of death was 1.91 times higher for children with MUAC < 115 mm than for those with MUAC ≥ 115 mm [AOR = 1.91 at 95% CI (1.05, 3.50)]. Children infected with HIV were 3.90 times more likely to die compared to their counterparts [AOR = 3.90 at 95% CI (2.80, 9.41)]. Particular emphasis should be placed on partnering with communities to improve information on malnutrition signs and on critical importance of early referral to the health system. While HIV incidence in DRC is still low (0.21%), its impact on mortality among severely malnourished children is increased due to the limited access to HIV testing and antiretroviral therapy.

27 May 2020 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
NBNordin Bansaccal
Nordin Bansaccal
DLDimitri Van der Linden
Dimitri Van der Linden
JMJean-Christophe Marot
Jean-Christophe Marot
LBLeïla Belkhir
Leïla Belkhir
Introduction: In most industrialized countries, human immunodeficiency virus (HIV) infection remains a formal contraindication to breastfeeding. However, for the past 9 years, the World Health Organization (WHO) has recommended, for developing countries, that mothers infected with HIV and treated by combined antiretroviral therapy (cART) should breastfeed their infants. HIV-infected women coming from developing countries and living in industrialized settings are increasingly expressing their natural desire to breastfeed. To avoid uncontrolled breastfeeding practices and reduce the risk of mother-to-child transmission of the virus, there is an urgent need to consider the wishes of these women. Discussion: We report two cases in which specific guidelines were implemented in order to support the mothers' choice to breastfeed in Belgium. As a result of different prophylactic measures including antiretrovirals in mothers and infants and close follow-up, none of the infants were infected. Conclusions: National or international recommendations for HIV-infected mothers who choose to breastfeed in industrialized countries remain unclear and discordant. There is an unmet need for experts to address this emerging issue and to develop an international consensus for the monitoring and prophylactic management of exposed-infants.